Shinichi Koizumi
Directeur/Membre du Conseil chez TSUBOTA LABORATORY INCORPORATED
Profil
Shinichi Koizumi is currently the Director, Vice President & CSO at AskAt, Inc. He is also an Independent Outside Director at Tsubota Laboratory, Inc. In the past, he served as the Executive Vice President at RaQualia Pharma, Inc. Dr. Koizumi holds a doctorate degree from Tokyo Institute of Technology, which he obtained in 1986.
Postes actifs de Shinichi Koizumi
| Sociétés | Poste | Début |
|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Directeur/Membre du Conseil | 01/06/2020 |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Anciens postes connus de Shinichi Koizumi
| Sociétés | Poste | Fin |
|---|---|---|
| RAQUALIA PHARMA INC. | Directeur Technique/Scientifique/R&D | 29/11/2012 |
Formation de Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Entreprise privées | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
